According to Zoetis's latest financial reports and stock price the company's current number of shares outstanding is 460,300,000. At the end of 2023 the company had 460,300,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 0.46 B | -1.14% |
2022 | 0.46 B | -1.59% |
2021 | 0.47 B | -0.5% |
2020 | 0.47 B | -0.19% |
2019 | 0.47 B | -0.87% |
2018 | 0.48 B | -1.38% |
2017 | 0.48 B | -1.34% |
2016 | 0.49 B | -0.87% |
2015 | 0.49 B | -0.66% |
2014 | 0.50 B | 0.31% |
2013 | 0.50 B | 4.95% |
2012 | 0.47 B | 0% |
2011 | 0.47 B |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Pfizer PFE | 5,647,000,000 | 1,126.81% | ๐บ๐ธ USA |
Eli Lilly LLY | 949,379,000 | 106.25% | ๐บ๐ธ USA |
Sanofi SNY | 2,507,200,000 | 444.69% | ๐ซ๐ท France |
Merck MRK | 2,554,166,667 | 454.89% | ๐บ๐ธ USA |
Phibro Animal Health
PAHC | 40,504,000 | -91.20% | ๐บ๐ธ USA |
Kindred Biosciences
KIN | 39,289,600 | -91.46% | ๐บ๐ธ USA |
Heska Corporation
HSKA | 10,390,000 | -97.74% | ๐บ๐ธ USA |